HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top
2025 · Molecules · 13 citations
https://doi.org/10.3390/molecules30122645
E
Elena Battaiotto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
100
Citations
5
h-index
2
i10-index
Elena Battaiotto is an academic researcher from University of Milan. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Lung Cancer Treatments and Mutations. The author has an h-index of 5, co-authored 22 publications.
Papers by this author
worksMolecular tumor board in patients with metastatic breast cancer
2024 · Breast Cancer Research and Treatment · 7 citations
https://doi.org/10.1007/s10549-024-07535-z
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis
2025 · The Oncologist · 2 citations
https://doi.org/10.1093/oncolo/oyaf012
Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study
2024 · ESMO Open · 1 citations
https://doi.org/10.1016/j.esmoop.2024.103662
336P Approaches for locoregional optimization in oligometastatic and oligopersistent metastatic breast cancer
2025 · ESMO Open · 1 citations
https://doi.org/10.1016/j.esmoop.2025.104908
1835 Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer
2025 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(25)00681-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat